Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: Results of a multicenter, phase II, dose-ranging study.
暂无分享,去创建一个
A. So | N. Schlesinger | U. Arulmani | A. Yücel | D. Richard | M. De Meulemeester | P. Sallstig | A. Pikhlak | V. Murphy | A. Eftal Yücel